158 related articles for article (PubMed ID: 37127145)
1. Population-Attributable Fractions of Nonalcoholic Fatty Liver Disease on All-Cause and Cause-Specific Mortality Risk: How Large is the Impact?
Qin L; Zhang K; Xie J
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):430. PubMed ID: 37127145
[No Abstract] [Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality.
de Avila L; Henry L; Paik JM; Ijaz N; Weinstein AA; Younossi ZM
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2588-2596.e3. PubMed ID: 36646233
[TBL] [Abstract][Full Text] [Related]
3. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease.
Wang XJ; Malhi H
Ann Intern Med; 2018 Nov; 169(9):ITC65-ITC80. PubMed ID: 30398639
[TBL] [Abstract][Full Text] [Related]
5. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
[TBL] [Abstract][Full Text] [Related]
6. Muscle strength in non-alcoholic fatty liver disease and all-cause and cause-specific mortality.
Kim D; Dennis BB; Wijarnpreecha K; Cholankeril G; Ahmed A
Liver Int; 2023 Feb; 43(2):513-516. PubMed ID: 36520009
[No Abstract] [Full Text] [Related]
7. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease.
Konyn P; Ahmed A; Kim D
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S43-S57. PubMed ID: 36417893
[TBL] [Abstract][Full Text] [Related]
8. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort.
Post A; Garcia E; van den Berg EH; Flores-Guerrero JL; Gruppen EG; Groothof D; Westenbrink BD; Connelly MA; Bakker SJL; Dullaart RPF
Eur J Clin Invest; 2021 Dec; 51(12):e13627. PubMed ID: 34120339
[TBL] [Abstract][Full Text] [Related]
10. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications.
Boutari C; Lefkos P; Athyros VG; Karagiannis A; Tziomalos K
Curr Vasc Pharmacol; 2018; 16(3):214-218. PubMed ID: 28676025
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease: a systematic review.
Rinella ME
JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
[TBL] [Abstract][Full Text] [Related]
13. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
[TBL] [Abstract][Full Text] [Related]
14. The association of hepatic steatosis and fibrosis with heart failure and mortality.
Park J; Kim G; Kim H; Lee J; Lee YB; Jin SM; Hur KY; Kim JH
Cardiovasc Diabetol; 2021 Sep; 20(1):197. PubMed ID: 34583706
[TBL] [Abstract][Full Text] [Related]
15. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
Younossi Z; Henry L
Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.
Fargion S; Porzio M; Fracanzani AL
World J Gastroenterol; 2014 Oct; 20(37):13306-24. PubMed ID: 25309067
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández Mijares A; Mantilla T; Millán J; Pedro-Botet J;
Clin Investig Arterioscler; 2017; 29(3):141-148. PubMed ID: 27692633
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
Fierbinteanu-Braticevici C; Sinescu C; Moldoveanu A; Petrisor A; Diaconu S; Cretoiu D; Braticevici B
Cell Biol Toxicol; 2017 Feb; 33(1):5-14. PubMed ID: 27680752
[TBL] [Abstract][Full Text] [Related]
20. The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis.
Buchman AL; Naini BV; Spilker B
Semin Liver Dis; 2017 Feb; 37(1):33-44. PubMed ID: 28201847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
